To evaluate the effect of soluble CD14 (sCD14) on human neutrophil res
ponse to lipopolysaccharide (LPS), we developed an LPS-priming assay t
hat measures the chemiluminescence response to N-formyl-methionyl-leuc
yl-phenylalanine stimulation, Priming by 1 ng/mL rough LPS occurred in
the presence of either serum or recombinant LPS-binding protein (LBP)
only, Priming was completely CD14-dependent because preincubation of
the neutrophils with an anti-CD14 monoclonal antibody prevented primin
g, We hypothesize that sCD14 enhances LPS response in neutrophils, but
this response is not as effective as LPS response via membrane CD14 (
mCD14). In our experiments sCD14 is present in an excess compared with
mCD14. Priming of neutrophils occurs with low LBP, supposedly via sCD
14-LPS complexes, With high LBP, addition of sCD14 inhibited LPS-primi
ng of neutrophils, In that case, LPS may be transported to sCD14, prev
enting a more effective response via mCD14. In this study we demonstra
te that the effect of sCD14 on neutrophil response to LPS is a delicat
e balance between activation and inhibition depending on concentration
of serum or LBP.